A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

Phase 3

Completed

• Conditions: Glaucoma, Angle-Closure; Ocular Hypertension

• Registration Number: NCT00051181
• Lead Sponsor: Alcon Research

Brief Summary

To demonstrate that the intraocular pressure(IOP)-lowering efficacy of Travoprost (0.004%) is equal or better than that of Latanoprost 0.005% in patients with chronic angle-closure glaucoma.

Detailed Description

Not available

Study Timeline

• Study Start: 2000-01
• Study First Submitted: 2003-01-03
• Study First Submitted QC: 2003-01-06
• Study First Posted: 2003-01-07
• Primary Completion: 2003-06
• Study Completion: 2003-06
• Status Verified: 2008-08
• Last Update Submitted: 2008-08-04
• Last Update Posted: 2008-08-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (2)

Asia; 🇺🇸 Fort Worth, Texas, United States

Australia; 🇦🇺 Sidney, Australia